Gene · 2923
Papers3,219
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,219
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting CALR reduces energy metabolism of esophageal cancer cells and inhibits tumor‑associated fibroblast infiltration. | Int J Oncol | 2025 | 40417915 | PubTator, text mining | PubMed |
| Multi-omics analyses develop and validate the optimal prognostic model on overall survival prediction for resectable hepatocellular carcinoma. | J Gastrointest Oncol | 2025 | 40386602 | PubTator, text mining | PubMed |
| Deciphering the Molecular Crosstalk of Endoplasmic Reticulum Stress and Immune Infiltration in Endometriosis. | Am J Reprod Immunol | 2025 | 40371728 | PubTator, text mining | PubMed |
| Identification of potential therapeutic targeting in ovarian aging from genetic screening with clinical validation. | J Assist Reprod Genet | 2025 | 40343599 | PubTator, text mining | PubMed |
| Glycosylation as an intricate post-translational modification process takes part in glycoproteins related immunity. | Cell Commun Signal | 2025 | 40325416 | PubTator, text mining | PubMed |
Statement of Retraction: Protein disulfide-isomerase A3 knockdown attenuates oxidized low-density lipoprotein-induced oxidative stress, inflammation and endothelial dysfunction in human umbilical vein endothelial cells by downregulating activating transcription factor 2. | Bioengineered | 2025 | 40267152 | PubTator, text mining | PubMed |
| Deleterious KOs in the HLA Class I Antigen Processing and Presentation Machinery Induce Distinct Changes in the Immunopeptidome. | Mol Cell Proteomics | 2025 | 40113210 | PubTator, text mining | PubMed |
| The potential applications of peptide-loading complex in cancer treatment. | Front Immunol | 2025 | 40098955 | PubTator, text mining | PubMed |
| Exploring druggable targets and inflammation-mediated pathways in cancer: a Mendelian randomization analysis integrating transcriptomic and proteomic data. | Inflamm Res | 2025 | 40038097 | PubTator, text mining | PubMed |
| Pdia3 deficiency exacerbates intestinal injury by disrupting goblet and Paneth cell function during ischemia/reperfusion. | Cell Signal | 2025 | 39988288 | PubTator, text mining | PubMed |
| Potential drug targets for ovarian cancer identified through Mendelian randomization and colocalization analysis. | J Ovarian Res | 2025 | 39972314 | PubTator, text mining | PubMed |
| Recent advances in vascular thiol isomerases: insights into structures, functions in thrombosis and antithrombotic inhibitor development. | Thromb J | 2025 | 39962537 | PubTator, text mining | PubMed |
| Galloylated polyphenols represent a new class of antithrombotic agents with broad activity against thiol isomerases. | J Thromb Haemost | 2025 | 39952360 | PubTator, text mining | PubMed |
| The NLRP3 activation-related signature predicts the diagnosis and indicates immune characteristics in endometriosis. | J Reprod Immunol | 2025 | 39904070 | PubTator, text mining | PubMed |
| A cellular model of TDP-43 induces phosphorylated TDP-43 aggregation with distinct changes in solubility and autophagy dysregulation. | FEBS J | 2025 | 39887552 | PubTator, text mining | PubMed |
| Proteomics for Biomarker Discovery in Gynecological Cancers: A Systematic Review. | J Proteome Res | 2025 | 39698999 | PubTator, text mining | PubMed |
| PDIA3 rs2788: An Independent Risk Factor for Hypertension and Its Interaction With Antihypertensive Medications. | J Clin Hypertens (Greenwich) | 2025 | 39686834 | PubTator, text mining | PubMed |
| Transcriptomic analysis of melatonin on the mechanism of embryonic gonadal development in female Jilin white geese. | Poult Sci | 2025 | 39566171 | PubTator, text mining | PubMed |
| G3BP2 promotes tumor progression and gemcitabine resistance in PDAC via regulating PDIA3-DKC1-hENT in a stress granules-dependent manner. | Acta Pharmacol Sin | 2025 | 39289547 | PubTator, text mining | PubMed |
| Pharmacologic Targeting of PDIA1 Inhibits NLRP3 Inflammasome Assembly and Activation. | Isr J Chem | 2024 | 40370770 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2923/papers?page=5